Effects of linker length and flexibility on multivalent targeting
Thomas A Shewmake1, Francisco J Solis, Robert J Gillies
1Harrington Department of Bioengineering and Center for Interventional Biomaterials, Arizona State University, Tempe, Arizona 85287, USA.
Biomacromolecules
|October 3, 2008
Summary
Molecular targeting constructs with optimal linker flexibility enhance drug delivery specificity. This study models linker length and flexibility to improve binding avidity and targeted therapy design.
Area of Science:
- Biomolecular Engineering
- Computational Biology
- Drug Delivery Systems
Background:
- Multivalent molecular constructs enhance specific cell binding for targeted drug delivery.
- Understanding linker properties is crucial for optimizing construct performance.
Purpose of the Study:
- To mathematically model the impact of linker length and flexibility on the binding avidity and specificity of divalent molecular targeting constructs.
- To derive a binding enhancement factor (VR) quantifying the increased rate of the second binding event.
Main Methods:
- Developed four mathematical models for linker flexibility: random coil, rigid rod, jointed rods, and combined rod-random coil.
- Derived a binding enhancement factor (VR) for each linker model.
- Analyzed the influence of VR, receptor density, and ligand concentration on specificity.
Main Results:
- Moderately flexible linker models best reproduced experimentally measured binding avidities.
- The binding enhancement factor (VR) significantly influences achievable specificity, alongside receptor density and ligand concentration.
- The study elucidates key design considerations for multivalent constructs.
Conclusions:
- Linker length and flexibility are critical parameters in designing effective multivalent targeting constructs.
- Mathematical modeling provides insights into optimizing constructs for targeted therapy and imaging applications.
- Tailoring linker properties can significantly improve drug delivery efficacy and specificity.
Related Concept Videos
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.